Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 187 Show results per page	View Search Criteria \| Help With Results

Last Modified: 2/15/2006


1.		Phase II/III Master Protocol for Chemotherapy with DTIC/ACT-D vs CACP/VBL/BLEO vs Phase II Agent with or without Prophylactic Cranial Radiotherapy for Disseminated Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				NCI				SWOG-8107

Last Modified: 8/10/2007


2.		Phase II/III Pilot Combination Chemotherapy and Radiotherapy for Previously Untreated Childhood ALL with Poor Prognosis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				under 21				NCI				CCG-192P

Last Modified: 4/5/2007


3.		Phase II/III Study of L-PAM or IPP/Mesna, Followed by Conventional Chemotherapy with VCR/CTX/ADR plus CTX/VCR/ACT-D/ADR, Surgery, and Radiotherapy, for Stage IIB/IIC/IIIA/IIIB Rhabdomyosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				under 18				NCI				SJCRH-RMS-V NCI-T86-0152D, T86-0152


4.		Phase II-III Chemotherapy with ACT-D/5-FU/CTX and/or Radiotherapy for Malignant Tumors of the Ovarian Stroma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				GOG-14

Last Modified: 6/28/2006 First Published: 12/1/1994


5.		Phase III Study of Multimodality Therapy Based on Prior Therapy and Histology in Patients With Relapsed Wilms' Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				21 and under at diagnosis				NCI				COG-Q9402 NWTS-Q9402, CCG-4942, POG-9444, INT-0152, NWTS-5/R, NCT00002610, Q9402

Last Modified: 11/10/2008 First Published: 12/1/1994


6.		Phase III Multimodality Therapy Based on Histology, Stage, Age, and Tumor Size in Children With Wilms' Tumor, Clear Cell Sarcoma of the Kidney, or Rhabdoid Tumors of the Kidney

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				Under 16				NCI				COG-Q9401 NWTS-Q9401, CCG-4941, POG-9440, INT-0150, NWTS-5, NCT00002611, Q9401

Last Modified: 8/10/2006


7.		Phase III Randomized Study of Induction With the ALL-2 Regimen (Cytarabine and High-Dose Mitoxantrone Based) Versus the L-20 Regimen (Vincristine and Prednisone Based) in Adults With Acute Lymphoblastic Malignancy: The ALL-4 Protocol

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Other				MSKCC-96015A1 NCI-V96-0881, NCT00002766

Last Modified: 8/10/2006 First Published: 12/1/1996


8.		Phase III Study of Surgery Followed By Chemotherapy in Patients With Nonmetastatic Soft Tissue Sarcoma With Randomization to 3-Drug Versus 6-Drug Continuation Therapy in Patients With High-Risk Chemosensitive Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Under 18				Other				SIOP-MMT-95 EU-96035, NCT00002898

Last Modified: 10/22/2007 First Published: 6/1/1997


9.		Phase III Study of Dactinomycin and Vincristine With or Without Cyclophosphamide and/or Radiotherapy in Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma of Embryonal or Botryoid Subtype

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				Under 50				NCI				COG-D9602 CCG-D9602, POG-D9602, IRS-D9602, D9602, NCT00002995

Last Modified: 6/11/2008 First Published: 2/1/1999


10.		Phase III Randomized Study of Methotrexate Versus Dactinomycin in Patients With Low-Risk Gestational Trophoblastic Neoplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Not specified				NCI				GOG-174 ECOG-G174, GOG-0174, NCT00003702

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute